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Activation of AMP-Activated Protein Kinase Leads
to the Phosphorylation of Elongation Factor 2
and an Inhibition of Protein Synthesis
resulting in the phosphorylation and inactivation of
eEF2, provides a novel mechanism for the inhibition
of protein synthesis.
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Figure 1. Time Course of the Effects of Anoxia and AICA Riboside on AMPK Activity, Protein Synthesis, eEF2 Phosphorylation, and eEF2
Kinase Activity in Incubations of Hepatocytes
(A–E) Hepatocytes were incubated under normoxic conditions (open squares), under anoxia (filled triangles), or in the presence of 1 mM AICA
riboside (filled circles). At the indicated times, cells were collected by centrifugation for (A) AMPK assay or for the (B) measurement of protein
synthesis, as described in the Experimental Procedures. The results are the means  SEM of at least three separate experiments. In (C),
extracts (25 g) were subjected to SDS-PAGE and were immunoblotted with anti-phospho (Thr56) eEF2 antibody (upper panel). The membrane
was stripped and probed with an anti-full-length eEF2 antibody that does not distinguish the phosphorylated protein (lower blot). In (D),
hepatocytes were preincubated with and without rapamycin and were incubated in the presence and absence of oliogomycin for 10 min.
Extracts were then immunoblotted as in (C). In parallel incubations, it was verified that rapamycin was effective, as the glutamine-induced
activation of p70S6K was blocked (not shown). For (C) and (D), the results of a representative experiment are shown. In (E), hepatocytes were
incubated with 1 mM AICA riboside, and extracts were prepared at the indicated times for eEF2 kinase assay with 1 M free Ca2. The results
are the means  SEM of three separate experiments. An asterisk indicates a significant activation of eEF2 kinase (p  0.05) compared with
the control.
Figure S2 in the Supplementary Material). In CHO-K1 investigated the possible involvement of the inhibition
of mTOR signaling in the increased phosphorylation ofcells treated with AICA riboside, the increase in eEF2
phosphorylation was maximal after 20–30 min of incuba- eEF2 in CHO-K1 cells incubated with increasing concen-
trations of 2-deoxyglucose to progressively deplete in-tion and was dependent on the dose of AICA riboside
(see Figure S3 in the Supplementary Material). In these tracellular ATP. In these experiments, we verified that
AMPK was activated by monitoring the increase in phos-cells, eEF2 phosphorylation also increased following
treatment with the uncoupler carbonyl cyanide m-chlo- phorylation of Ser79 of acetyl-CoA carboxylase (Figure
2). With increasing 2-deoxyglucose concentrations,rophenyl-hydrazone (not shown).
mTOR has been suggested to act as an ATP sensor leading to a maximum level of eEF2 phosphorylation,
there was little reduction in the already substantial ex-with a Km for ATP for the phosphorylation of p70 ribo-
somal protein S6 kinase (p70S6K) and 4E-BP1 of about tent of phosphorylation of p70S6K and 4E-BP1, as as-
sessed by band shifts, and the phosphorylation state1 mM [4]. Moreover, p70S6K lies downstream of mTOR
and phosphorylates and inactivates eEF2 kinase, the of ribosomal protein S6 was unaffected (Figure 2). There-
fore, a reduction in mTOR signaling cannot explain theeffect being blocked by rapamycin [5]. Therefore, we
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Figure 2. Effect of Increasing Concentra-
tions of 2-Deoxyglucose on the Phosphoryla-
tion State of eEF2 and Downstream Compo-
nents in the mTOR Signaling Pathway
Serum-fed CHO-K1 cells were incubated with
the indicated concentrations of 2-deoxyglu-
cose in the presence and absence of insulin
(0.1M) Extracts were prepared as described
in the Experimental Procedures and were
blotted with the antibodies indicated follow-
ing SDS-PAGE. -(P)S79-ACC was used to
monitor AMPK activation corresponding to
the phosphorylation site for AMPK in acetyl-
CoA carboxylase (Ser79). For 4E-BP1, two
bands are visible, the lower  and upper 
forms. For p70S6K, the three bands indicated
by arrows represent different phosphorylated
species, and insulin causes a shift to the
slowest most-phosphorylated form.
increase in eEF2 phosphorylation in cells incubated with activation inhibits protein synthesis. AMPK is not acti-
vated by AICA riboside treatment in these cells [10].low 2-deoxyglucose concentrations to activate AMPK.
At 10 mM 2-deoxyglucose, there was a hint of a band However, as demonstrated previously [10], AMPK can
be activated in HEK293 cells by treatment with oligomy-shift for p70S6K, which would indicate a decrease in
activity. Thus, at very high 2-deoxyglucose concentra- cin (Figure 3A). Transfection with the dominant-negative
1 AMPK construct did not decrease basal AMPK activ-tions (Dennis et al. used up to 100 mM 2-deoxyglucose
in their studies, [4]), which severely deplete ATP levels ity, as shown previously [10]. This might be due to the
trimeric nature of AMPK and the existence of both 1[4], a decrease in p70S6K via a decrease in mTOR signal-
ing could contribute to eEF2 phosphorylation via an and 2 catalytic subunits. However, transfection with a
dominant-negative 1 AMPK mutant almost completelyincrease in eEF2 kinase activity.
In isolated hepatocytes, both the basal and anoxia- abolished AMPK activation by oligomycin (Figure 3A).
In our previous studies conducted under exactly theinduced inhibition of protein synthesis were unaffected
by rapamycin (not shown). Furthermore, rapamycin had same conditions, there was no effect of transfection of
the dominant-negative construct on the levels of endog-no effect on the basal (Figure 1D) and anoxia-induced
phosphorylation of eEF2 (not shown), and this suggests enous or transfected AMPK isoforms, as verified by im-
munoblotting [10]. A wild-type 1 AMPK vector wasthat p70S6K is not active and that mTOR is not mediating
these effects. For AMPK to inhibit protein synthesis by used as a control and did not increase AMPK activity,
as demonstrated previously [10]. Transfection with dom-interfering with mTOR-dependent signaling, the system
would first need to be activated, e.g., by amino acids inant-negative 1 AMPK slightly decreased the basal
rate of protein synthesis, but the effect was not statisti-or insulin. In isolated hepatocytes, p70S6K activity is
very low under basal conditions, but it can be activated cally significant (control rates of protein synthesis were
0.15, 0.15, and 0.17 nmol/min/mg of protein and 0.12,upon incubation with amino acids, via mTOR, and this
activation is blocked by rapamycin [6]. Indeed, the 0.12, and 0.15 nmol/min/mg in the dominant-negative
1 AMPK-transfected cells). In cells treated with oligo-amino acid-dependent phosphorylation and activation
of p70S6K in hepatocytes was recently shown to be mycin, the rate of protein synthesis was decreased by
about 60%, and transfection with the dominant-negativeinhibited by AMPK activation [7, 8]. Also, AMPK activa-
tion by AICA riboside in rat skeletal muscle in vivo inhib- 1 AMPK blocked its inhibitory effect (Figure 3B). More-
over, transfection of dominant-negative 1 AMPK re-ited both the mTOR pathway and protein synthesis [9].
HEK293 cells were transfected with dominant-nega- duced the oligomycin-induced phosphorylation of eEF2
to control levels (Figure 3C).tive 1 AMPK to provide additional evidence that AMPK
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We tested whether eEF2 was a direct substrate for
AMPK. Although the protein could be phosphorylated
by AMPK in vitro, the stoichiometry of phosphate incor-
poration was low, reaching a plateau of 0.1–0.2 mol/mol
after 30 min of incubation, indicating that eEF2 is a
poor substrate (not shown). This low stoichiometry of
phosphorylation could not be increased by prior de-
phosphorylation of eEF2 with protein phosphatase 2A
catalytic subunits, and the anti-eEF2 Thr56(P) antibody
revealed that AMPK did not phosphorylate this residue
(not shown). In addition, the sequence around Thr56 of
eEF2 does not fit the consensus requirements for AMPK
[1]. We therefore tested whether eEF2 kinase itself was
activated by conditions that activated AMPK. In hepato-
cytes incubated for 10 min in anoxia (not shown) or with
AICA riboside (Figure 1E), eEF2 kinase was activated
by about 2-fold. The activation was rapid, reaching a
maximum after 6 min of treatment with AICA riboside
(Figure 1E).
The inhibition of protein synthesis by oxygen depriva-
tion is a well-known observation [11–16]. Surprisingly,
the molecular mechanisms behind this phenomenon
have received little attention, although changes in the
association of 4E-BP1 and eIF4E have been reported
[17, 18]. Here, we confirm that anoxia inhibits protein
synthesis in isolated hepatocytes and, under these con-
ditions, AMPK was activated and the phosphorylation
state of eEF2 was increased. Likewise, AICA riboside
inhibited protein synthesis and increased eEF2 phos-
phorylation. The phosphorylation and inactivation of
eEF2 is a logical mechanism for pausing translation tem-
porarily at elongation. Translation could then resume
quickly following a return to normal ATP levels. Regulat-
ing initiation, on the other hand, would cause polysomes
to dissociate and would have varying effects on different
mRNAs. In this respect, it is noteworthy that, in hepato-
cytes, the shut down in protein synthesis after 30 min
of anoxia can be fully reversed upon reoxygenation [11].
Purified rat liver eEF2 was a poor substrate of AMPK,
which suggests that the increase in eEF2 phosphoryla-
tion might be a consequence of eEF2 kinase activation
rather than direct phosphorylation of eEF2 by AMPK.
Indeed, eEF2 kinase was activated by anoxia or AICA
riboside treatment, suggesting that AMPK activation
mediates this effect.
Supplementary Material
Supplementary material including the Experimental Procedures can
be found at http://images.cellpress.com/supmat/supmatin.htm.
Also included are figures showing the effects of various treatments
on the level of Ser51 phosphorylation of eIF2 in hepatocytes and
Figure 3. Effect of Dominant-Negative AMPK on the Oligomycin- CHO-K1 cells together with the effects of treatments on the phos-
Induced Activation of AMPK, Protein Synthesis Inhibition, and eEF2 phorylation state of 4E-BP1 in hepatocytes (Figure S1). Other figures
Phosphorylation in Transfected HEK293 Cells show isoelectric focusing and eEF2 detection in extracts from an-
(A–C) HEK293 cells were transfected with 10 g 1 AMPK DNA or oxic and AICA riboside-treated hepatocytes (Figure S2) and a time
10 g 1DN AMPK DNA (see the Supplementary Material). Cells course and dose dependence of eEF2 phosphorylation in CHO-K1
were incubated with and without oligomycin for 15 min for the mea- cells (Figure S3).
surements of (A) AMPK activity and (B) protein synthesis. The results
are the means  SEM of three separate experiments. An asterisk
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